From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy ; volume:8 ; number:2 ; day:16 ; month:1 ; year:2024 ; pages:251-261 ; date:3.2024
PharmacoEconomics - open ; 8, Heft 2 (16.1.2024), 251-261, 3.2024
- Classification
-
Wirtschaft
- Creator
-
Rossini, Elvio Emanuele
Galeone, Carlotta
Lucchetti, Chiara
Jommi, Claudio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s41669-023-00467-2
- URN
-
urn:nbn:de:101:1-2404301254021.463224923574
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rossini, Elvio Emanuele
- Galeone, Carlotta
- Lucchetti, Chiara
- Jommi, Claudio
- SpringerLink (Online service)
Other Objects (12)
Drug pricing and reimbursement decision making systems in Mongolia
Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance
On the welfare analysis of external reference pricing and reimbursement policy
Pricing and reimbursement of orphan drugs: the need for more transparency
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
Indication-wide drug pricing: Insights from the pharma market
Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries
A negotiation-based model of tax-induced transfer pricing
A Negotiation-Based Model of Tax-Induced Transfer Pricing
Value-Based Indication-Specific Pricing and Weighted-Average Pricing: Estimated Price and Cost Savings for Cancer Drugs
Drug pricing and reimbursement decision making systems in Mongolia
Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance
On the welfare analysis of external reference pricing and reimbursement policy
Pricing and reimbursement of orphan drugs: the need for more transparency
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
Indication-wide drug pricing: Insights from the pharma market
Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries
A negotiation-based model of tax-induced transfer pricing
A Negotiation-Based Model of Tax-Induced Transfer Pricing
Value-Based Indication-Specific Pricing and Weighted-Average Pricing: Estimated Price and Cost Savings for Cancer Drugs
Drug pricing and reimbursement decision making systems in Mongolia
Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance
On the welfare analysis of external reference pricing and reimbursement policy
Pricing and reimbursement of orphan drugs: the need for more transparency
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
Indication-wide drug pricing: Insights from the pharma market
Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries
A negotiation-based model of tax-induced transfer pricing
A Negotiation-Based Model of Tax-Induced Transfer Pricing